Clinical Trial Update: Chemotherapy and Bevacizumab With or Without Radiofrequency Ablation in Treating Unresectable Liver Metastases in Patients With Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating bevacizumab with chemotherapy, with or without radiofrequency ablation, for unresectable liver metastases from colorectal canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Colorectal Cancer, Metastatic Cancer | Phase 2 | Status: TERMINATED